Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06330168

Paravertebral Calcitonin in Thoracotomy

The Analgesic Value of Paravertebral Calcitonin in Patients Undergoing Thoracotomy

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective randomized double-blinded controlled study will be conducted to evaluate the effect of adding calcitonin to bupivacaine in thoracic paravertebral block for patients undergoing thoracotomy.

Detailed description

Single-shot thoracic paravertebral block combined with intravenous analgesia is one of the regional techniques used for controlling pain in patients undergoing thoracic surgery. However, few articles demonstrated its effects on acute pain and chronic pain after thoracotomy and revealed high postoperative opioid consumption and inability to reduce the incidence of chronic pain. Calcitonin has previously been shown to be effective in the management of acute pain following amputation, vertebral fractures and other neuropathic conditions. Using calcitonin as an additive in thoracic paravertebral block was not evaluated in previous studies, investigators conducted this study based on the hypothesis that calcitonin use as an additive in thoracic paravertebral block for patients undergoing thoracotomy may have extended analgesic effects regarding decreasing postoperative pain scores, opioid consumption, and this value may decrease the incidence of chronic post-thoracotomy pain. In both groups, ultrasound-guided thoracic paravertebral block will be performed before anesthetic induction using a high-frequency linear probe after identifying the paravertebral space of the proposed level of intercostal skin incision.General anesthesia in both groups will be similar.

Conditions

Interventions

TypeNameDescription
DRUGbupivacaine-calcitonin-fentanylpre-induction single shot thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 100 IU of calcitonin (1ml).
DRUGBupivacaine-fentanylpre-induction single shot thoracic paravertebral block using 20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml), and 1 ml saline 0.9%.

Timeline

Start date
2024-03-28
Primary completion
2025-05-14
Completion
2026-05-15
First posted
2024-03-26
Last updated
2026-02-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06330168. Inclusion in this directory is not an endorsement.

Paravertebral Calcitonin in Thoracotomy (NCT06330168) · Clinical Trials Directory